tradingkey.logo

Cooper Companies Inc

COO

67.395USD

+2.815+4.36%
Close 08/29, 16:00ETQuotes delayed by 15 min
13.40BMarket Cap
32.35P/E TTM

Cooper Companies Inc

67.395

+2.815+4.36%

TradingKey Stock Score

Financial Health

Valuation Dimension

Forecast

Momentum

Institutional Confidence

Risk Assessment

Peers

TradingKey Stock Score

Financial Health

Valuation Dimension

Forecast

Momentum

Institutional Confidence

Risk Assessment

Peers

TradingKey Stock Score

Currency: USD Updated2025-08-29

Key Insights

The company's fundamentals are relatively healthy.Its valuation is considered undervalued,and institutional recognition is very high.Over the past 30 days, multiple analysts have rated the company as a Buy.Despite an average stock market performance, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
75 / 280
Overall Ranking
188 / 4751
Industry
Healthcare Services & Equipment

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analysts' Target

Based on 19 analysts
Buy
Current Rating
86.027
Target Price
+27.65%
Upside Space
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.74% year-on-year.
Undervalued
The company’s latest PE is 32.45, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 201.42M shares, decreasing 1.64% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 24.16M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.52.

Financial Health

Currency: USD Updated2025-08-29

The company's current financial score is 6.94, which is lower than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.00B, representing a year-over-year increase of 6.33%, while its net profit experienced a year-over-year increase of 1.35%.

Score

Industry at a Glance

Previous score
6.94
Change
0

Financials

6.19

Related Indicators

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

7.50

Operational Efficiency

7.21

Growth Potential

7.07

Shareholder Returns

6.72

Valuation Dimension

Currency: USD Updated2025-08-29

The company’s current valuation score is 1.80, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 35.68, which is 3.35% below the recent high of 36.88 and 4.49% above the recent low of 34.08.

Score

Industry at a Glance

Previous score
2.60
Change
-0.8

Valuation Dimension

P/E

P/B

P/S

P/CF

Industry Ranking 75/280
No Data

Forecast

Currency: USD Updated2025-08-29

The company’s current earnings forecast score is 7.79, which is higher than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Cooper Companies Inc is 94.00, with a high of 105.00 and a low of 84.00.

Score

Industry at a Glance

Previous score
7.79
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 19 analysts
Buy
Current Rating
86.027
Target Price
+27.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
7
Median
9
Average
Company name
Ratings
Analysts
Cooper Companies Inc
COO
19
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Momentum

Currency: USD Updated2025-08-29

The company’s current price momentum score is 9.11, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 77.07 and the support level at 69.62, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.89
Change
0.36

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(5)
Neutral(1)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-1.223
Sell
RSI(14)
39.199
Neutral
STOCH(KDJ)(9,3,3)
42.692
Sell
ATR(14)
2.542
High Vlolatility
CCI(14)
-192.187
Sell
Williams %R
59.172
Sell
TRIX(12,20)
0.010
Sell
StochRSI(14)
35.286
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
70.644
Sell
MA10
72.253
Sell
MA20
71.785
Sell
MA50
72.224
Sell
MA100
74.790
Sell
MA200
83.417
Sell

Institutional Confidence

Currency: USD Updated2025-08-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 100.96%, representing a quarter-over-quarter decrease of 1.88%. The largest institutional shareholder is The Vanguard, holding a total of 24.16M shares, representing 12.11% of shares outstanding, with 1.72% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
23.75M
-0.08%
BlackRock Institutional Trust Company, N.A.
9.88M
-0.39%
State Street Global Advisors (US)
8.55M
-1.48%
Capital World Investors
7.75M
+84.95%
Kayne Anderson Rudnick Investment Management, LLC
7.99M
-1.21%
T. Rowe Price Investment Management, Inc.
7.27M
-5.29%
T. Rowe Price Associates, Inc.
Star Investors
3.66M
+12.99%
Geode Capital Management, L.L.C.
5.08M
+3.49%
Neuberger Berman, LLC
3.61M
+41.65%
AllianceBernstein L.P.
3.88M
-14.29%
1
2

Risk Assessment

Currency: USD Updated2025-08-29

The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.46
Change
-0.38
Beta vs S&P 500 index
0.97
VaR
+2.51%
240-Day Maximum Drawdown
+41.94%
240-Day Volatility
+35.93%
Return
Best Daily Return
60 days
+5.58%
120 days
+8.95%
5 years
+11.84%
Worst Daily Return
60 days
-12.85%
120 days
-14.61%
5 years
-14.61%
Sharpe Ratio
60 days
+0.27
120 days
-0.90
5 years
-0.03
Risk Assessment
Maximum Drawdown
240 days
+41.94%
3 years
+41.94%
5 years
+45.46%
Return-to-Drawdown Ratio
240 days
-0.93
3 years
+0.07
5 years
-0.08
Skewness
240 days
-1.95
3 years
-0.13
5 years
-0.07
Volatility
Realised Volatility
240 days
+35.93%
5 years
+29.19%
Standardised True Range
240 days
+3.30%
5 years
+3.15%
Downside Risk-Adjusted Return
120 days
-94.98%
240 days
-94.98%
Maximum Daily Upside Volatility
60 days
+30.95%
Maximum Daily Downside Volatility
60 days
+36.49%
Liquidity
Average Turnover Rate
60 days
+1.35%
120 days
+1.26%
5 years
--
Turnover Deviation
20 days
+99.02%
60 days
+111.38%
120 days
+96.25%

Peers

Currency: USD Updated2025-08-29
Cooper Companies Inc
Cooper Companies Inc
COO
6.42 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
Merit Medical Systems Inc
MMSI
7.76 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
Tenet Healthcare Corp
THC
7.66 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
View more

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.

KeyAI